Technology | 2019.11.20
Northwestern University Licenses Promising Autoimmune Technology to Temprian Therapeutics
Initial program includes the development of a treatment to reverse vitiligo, a skin pigmentation disorder affecting 50 million people worldwide
(PRWeb November 20, 2019)
Read the full story at https://www.prweb.com/releases/northwestern_university_licenses_promising_autoimmune_technology_to_temprian_therapeutics/prweb16731402.htm
For more information, please visit
https://www.prweb.com/releases/northwest[...]therapeutics/prweb16731402.htm
